Literature DB >> 19760520

The role of VE-cadherin in osteosarcoma cells.

Li-Zhi Zhang1, Jiong Mei, Zhi-Kang Qian, Xuan-Song Cai, Yao Jiang, Wei-Da Huang.   

Abstract

Osteosarcoma cells can generate vasculogenic-like, patterned networks to obtain nutrients and oxygen, which mimic some function of endothelial-like cells and facilitate tumor malignant progress. These cells also express vascular endothelial-cadherin (VE-cadherin), which is generally accepted as a strictly endothelial-specific transmembrane protein. However, its role is still relatively obscure in osteosarcoma cells. So we inhibit the VE-cadherin gene expression with siRNA in osteosarcoma cells (MG63), and culture those cells in three-dimensional medium, containing Type I collagen or Matrigel, to observe the role of VE-cadherin. Western blotting analysis show that sequence-specific siRNA can significantly decrease the expression of VE-cadherin in MG63 cell. After knockdown of VE-cadherin, osteosarcoma cells can't induced angiogenic sprout and form osteosarcoma-generated, endothelial-like networks. Our data indicate that VE-cadherin may be a positive and specific regulator not only in angiogenesis, but also in vasculogenic mimicry of osteosarcoma cells. And it can be considered as a new prospective option in the combining treatment of aggressive tumor with highly vascularity, including osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19760520     DOI: 10.1007/s12253-009-9198-1

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  19 in total

Review 1.  Breaking the VE-cadherin bonds.

Authors:  Julie Gavard
Journal:  FEBS Lett       Date:  2008-12-04       Impact factor: 4.124

2.  Tumor origin of endothelial cells in human neuroblastoma.

Authors:  Annalisa Pezzolo; Federica Parodi; Maria Valeria Corrias; Roberta Cinti; Claudio Gambini; Vito Pistoia
Journal:  J Clin Oncol       Date:  2007-02-01       Impact factor: 44.544

3.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Authors:  A J Maniotis; R Folberg; A Hess; E A Seftor; L M Gardner; J Pe'er; J M Trent; P S Meltzer; M J Hendrix
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

4.  Cyclic AMP signaling as a mediator of vasculogenic mimicry in aggressive human melanoma cells in vitro.

Authors:  Jean-Claude Lissitzky; Danielle Parriaux; Elodie Ristorcelli; Alain Vérine; Dominique Lombardo; Patrick Verrando
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

Review 5.  Targeting cancer stem cells to modulate alternative vascularization mechanisms.

Authors:  Elena Monzani; Caterina Am La Porta
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

Review 6.  VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation.

Authors:  Dietmar Vestweber
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-12-27       Impact factor: 8.311

Review 7.  Structure of artificial and natural VE-cadherin-based adherens junctions.

Authors:  Jean-Christophe Taveau; Mathilde Dubois; Olivier Le Bihan; Sylvain Trépout; Sébastien Almagro; Elizabeth Hewat; Claire Durmort; Stéphanie Heyraud; Danielle Gulino-Debrac; Olivier Lambert
Journal:  Biochem Soc Trans       Date:  2008-04       Impact factor: 5.407

Review 8.  Angiogenesis: the VE-cadherin switch.

Authors:  Yann Wallez; Isabelle Vilgrain; Philippe Huber
Journal:  Trends Cardiovasc Med       Date:  2006-02       Impact factor: 6.677

Review 9.  Beyond vessels: occurrence and regional clustering of vascular endothelial (VE-)cadherin-containing junctions in non-endothelial cells.

Authors:  Judit Boda-Heggemann; Anne Régnier-Vigouroux; Werner W Franke
Journal:  Cell Tissue Res       Date:  2008-11-11       Impact factor: 5.249

10.  Gene expression analysis of embryonic stem cells expressing VE-cadherin (CD144) during endothelial differentiation.

Authors:  Vesna Nikolova-Krstevski; Manoj Bhasin; Hasan H Otu; Towia Libermann; Peter Oettgen
Journal:  BMC Genomics       Date:  2008-05-22       Impact factor: 3.969

View more
  9 in total

Review 1.  Anticancer Effects of Constituents of Herbs Targeting Osteosarcoma.

Authors:  Qing-Hong Su; Xiao-Qun Xu; Jun-Fu Wang; Jun-Wen Luan; Xia Ren; Hai-Yan Huang; Si-Shan Bian
Journal:  Chin J Integr Med       Date:  2019-06-04       Impact factor: 1.978

Review 2.  Progress in tumor vascular normalization for anticancer therapy: challenges and perspectives.

Authors:  Bingxue Shang; Zhifei Cao; Quansheng Zhou
Journal:  Front Med       Date:  2012-03-31       Impact factor: 4.592

3.  Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma.

Authors:  Wen-bin Liu; Ge-liang Xu; Wei-dong Jia; Jian-sheng Li; Jin-liang Ma; Ke Chen; Zhi-hua Wang; Yong-sheng Ge; Wei-hua Ren; Ji-hai Yu; Wei Wang; Xiu-Jun Wang
Journal:  Med Oncol       Date:  2010-10-19       Impact factor: 3.064

Review 4.  Tissue engineered models of healthy and malignant human bone marrow.

Authors:  Alan Chramiec; Gordana Vunjak-Novakovic
Journal:  Adv Drug Deliv Rev       Date:  2019-04-17       Impact factor: 15.470

5.  A 3D-printed scaffold-based osteosarcoma model allows to investigate tumor phenotypes and pathogenesis in an in vitro bone-mimicking niche.

Authors:  Mei-Ling Wang; Nian-Yuan Xu; Rui-Zhi Tang; Xi-Qiu Liu
Journal:  Mater Today Bio       Date:  2022-05-25

6.  Coaction of spheroid-derived stem-like cells and endothelial progenitor cells promotes development of colon cancer.

Authors:  Bo Wei; Xiao-Yan Han; Cui-Ling Qi; Shi Zhang; Zong-Heng Zheng; Yong Huang; Tu-Feng Chen; Hong-Bo Wei
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

Review 7.  Relevance of 3d culture systems to study osteosarcoma environment.

Authors:  Angela De Luca; Lavinia Raimondi; Francesca Salamanna; Valeria Carina; Viviana Costa; Daniele Bellavia; Riccardo Alessandro; Milena Fini; Gianluca Giavaresi
Journal:  J Exp Clin Cancer Res       Date:  2018-01-05

8.  Targeting circDGKD Intercepts TKI's Effects on Up-Regulation of Estrogen Receptor β and Vasculogenic Mimicry in Renal Cell Carcinoma.

Authors:  Jie Ding; Xin-Gang Cui; Hao-Jie Chen; Yin Sun; Wei-Wei Yu; Jie Luo; Guang-Qian Xiao; Chawnshang Chang; Jun Qi; Shuyuan Yeh
Journal:  Cancers (Basel)       Date:  2022-03-23       Impact factor: 6.639

Review 9.  Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression.

Authors:  Timothy M Fan; Ryan D Roberts; Michael M Lizardo
Journal:  Front Oncol       Date:  2020-01-31       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.